Preoperative Versus Postoperative Interscalene Block in Arthroscopic Rotator Cuff Repair

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorIstinye University

About this trial

This study is evaluating whether the timing of an interscalene nerve block affects pain control and recovery after arthroscopic rotator cuff repair surgery.

An interscalene block is commonly used to reduce pain after shoulder surgery. However, it is not known whether administering the block before surgery or after surgery provides better outcomes. Participants undergoing arthroscopic rotator cuff repair are assigned to receive the interscalene block either before the surgical incision or after completion of the procedure.

The study compares postoperative pain levels, opioid medication use, length of hospital stay, and ultrasound imaging quality during block administration between the two groups. Functional recovery is also assessed using patient-reported outcome measures during follow-up.

The investigators hypothesize that administration of the interscalene block before surgery may provide superior early pain control and reduce postoperative opioid requirements while maintaining similar functional outcomes compared with administration after surgery.

Eligibility criteria

Qualifiers

Adults aged 18 years or older.

Patients undergoing primary arthroscopic rotator cuff repair.

Presence of a repairable small-, medium-, or large-sized rotator cuff tear confirmed by clinical and imaging evaluation.

Receipt of an ultrasound-guided interscalene nerve block as part of perioperative pain management.

Disqualifiers

Irreparable rotator cuff tears.

Partial-thickness rotator cuff tears not requiring repair.

Revision rotator cuff repair procedures.

Concomitant shoulder procedures that could substantially influence postoperative pain or functional outcomes (e.g., shoulder arthroplasty, fracture fixation).

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

42 Participants
are grouped into 2 trial groups

Sponsors and collaborators